Objective: We assessed the prognostic value of electrocardiographic left ventricular hypertrophy (LVH) using Sokolow-Lyon (SL-LVH), Cornell Voltage (CV-LVH) or Cornell Product (CP-LVH) Criteria in 3043 hypertensive people aged 80 years and over enrolled in the Hypertens... View more
The HYVET trial is registered with ClinicalTrials.gov number NCT00122811 http://clinicaltrials.gov/ The committee members and investigators for HYVET were as follows: Co-ordinating Centre: C.J.Bulpitt (lead investigator], A.E. Fletcher (co-investigator), N.S. Beckett (trial coordinator), R.Peters (deputy trial coordinator), HYVET coordinating team at Imperial College London (1999 to 2008); HYVET Committees: Steering Committee: T. McCormack, J. Potter, B.G. Extremera, P. Sever, F. Forette, D. Dumitrascu, C.Swift, J. Tuomilehto, J. Coope (retired in 2001), C. Nachev (deceased); Data Monitoring Committee: J. Staessen, L. Thijs, R. Clarke, K.Narkiewicz; End Points Committee: C. Davidson (retired in 2003), J. Duggan, G. Leonetti, N. Gainsborough, M.C. De Vernejoul, J.Wang, V. Stoyanovsky; Dementia Validation Committee: J. Tuomilehto, R. Clarke, A.Waldman, I. Walton, C. Ritchie; Ethics Committee: R. Fagard, J. Grimley Evans, B. Williams; Investigators: (*National Co-ordinators) Australia - R. Warne* and I. Puddey*, M. Woodward, R.Penhall, C. Inderjeeth, S. Roger, R.
Scholes, C. Johnson; Belgium - H. Celis*, G. Adriaens, W. Onsea, K. Cornelli, D. Vantroyen, P. Cleen, P. de Voogt; Bulgaria - C. Nachev* (deceased) (national coordinator from 1998 to 2005), V. Stoyanovsky* (national coordinator after 2005), P. Solakov, R. Prokopova, E.